作者: Ildikó Demeter , Károly Nagy , Levente Gellért , László Vécsei , Ferenc Fülöp
DOI: 10.1007/S00702-011-0755-X
关键词:
摘要: The concentration of kynurenic acid (KYNA) in the cerebrospinal fluid, which is nanomolar range, known to decrease epilepsy. experimental data suggest that treatment with L: -KYN dose dependently increases neuroprotective KYNA brain, itself hardly crosses blood-brain barrier. However, it suggested new synthetic analogs may readily cross In this study, we tested hypothesis a analog administered systemically sufficient results decreased population spike activity recorded from pyramidal layer area CA1 hippocampus, and also provides protection against pentylenetetrazole-induced epileptiform seizures.